| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation
|
Schöber, Ch.
|
|
1992
|
19 |
2S3 |
p. 136-140
5 p.
|
artikel
|
| 2 |
Alfa-2a interferon and 5-fluorouracil for advanced colorectal carcinoma: The memorial sloan-kettering experience
|
Kemeny, Nancy
|
|
1992
|
19 |
2S3 |
p. 171-175
5 p.
|
artikel
|
| 3 |
A phase I trial of fluorouracil, leucovorin, and recombinant interferon α-2b in patients with advanced malignancy
|
Taylor, Charles W.
|
|
1992
|
19 |
2S3 |
p. 185-190
6 p.
|
artikel
|
| 4 |
A phase I trial of interferon α-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma
|
Kreuser, Ernst-D.
|
|
1992
|
19 |
2S3 |
p. 197-203
7 p.
|
artikel
|
| 5 |
Biochemical modulation of fluorouracil by dipyridamole: Preclinical and clinical experience
|
Grem, Jean L.
|
|
1992
|
19 |
2S3 |
p. 56-65
10 p.
|
artikel
|
| 6 |
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer
|
Wilke, Hansjochen
|
|
1992
|
19 |
2S3 |
p. 215-219
5 p.
|
artikel
|
| 7 |
Biochemical modulation of fluorouracil with leucovorin and interferon: Preclinical and clinical investigations
|
Grem, Jean L.
|
|
1992
|
19 |
2S3 |
p. 36-44
9 p.
|
artikel
|
| 8 |
Chemotherapeutic strategies in metastatic colorectal cancer: An overview of current clinical trials
|
Köhne-Wömpner, C-H.
|
|
1992
|
19 |
2S3 |
p. 105-125
21 p.
|
artikel
|
| 9 |
Clinical pharmacokinetics of fluorouracil and folinic acid
|
Schalhorn, Andreas
|
|
1992
|
19 |
2S3 |
p. 82-92
11 p.
|
artikel
|
| 10 |
Combination fluorouracil, folinic acid, and interferon alfa-2a: An active regimen in advanced pancreatic carcinoma
|
Knuth, Alexander
|
|
1992
|
19 |
2S3 |
p. 211-214
4 p.
|
artikel
|
| 11 |
Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: Influence of modulation with leucovorin
|
Lorenz, Matthias
|
|
1992
|
19 |
2S3 |
p. 163-170
8 p.
|
artikel
|
| 12 |
Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase
|
van der Wilt, Clasina L.
|
|
1992
|
19 |
2S3 |
p. 16-25
10 p.
|
artikel
|
| 13 |
Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro
|
Dempke, Wolfram C.M.
|
|
1992
|
19 |
2S3 |
p. 66-72
7 p.
|
artikel
|
| 14 |
Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer
|
Punt, C.J.A.
|
|
1992
|
19 |
2S3 |
p. 208-210
3 p.
|
artikel
|
| 15 |
Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer
|
Preiss, Joachim
|
|
1992
|
19 |
2S3 |
p. 220-224
5 p.
|
artikel
|
| 16 |
Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer—Preliminary results of a randomized trial
|
Steinke, Berthold
|
|
1992
|
19 |
2S3 |
p. 141-147
7 p.
|
artikel
|
| 17 |
High-dose fluorouracil: A new perspective in the treatment of colorectal cancer?
|
Wils, Jacques A.
|
|
1992
|
19 |
2S3 |
p. 126-130
5 p.
|
artikel
|
| 18 |
Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil
|
Schüller, Johannes
|
|
1992
|
19 |
2S3 |
p. 93-97
5 p.
|
artikel
|
| 19 |
Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: Preliminary results of a phase I/II trial
|
Schmoll, H.J.
|
|
1992
|
19 |
2S3 |
p. 191-196
6 p.
|
artikel
|
| 20 |
Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer—Results of a clinical phase II study
|
Hiddemann, W.
|
|
1992
|
19 |
2S3 |
p. 225-227
3 p.
|
artikel
|
| 21 |
Mechanisms of resistance to fluoropyrimidines
|
Zhang, Zheng-Gang
|
|
1992
|
19 |
2S3 |
p. 4-9
6 p.
|
artikel
|
| 22 |
Modulation of fluoropyrimidines: Role of dose and schedule of leucovorin administration
|
Zhang, Zheng-Gang
|
|
1992
|
19 |
2S3 |
p. 10-15
6 p.
|
artikel
|
| 23 |
Modulation of fluorouracil by N-(phosphonacetyl)-l-asparate: A review
|
Martin, Daniel S.
|
|
1992
|
19 |
2S3 |
p. 49-55
7 p.
|
artikel
|
| 24 |
Modulation of fluorouracil toxicity with uridine
|
van Groeningen, Cornelis J.
|
|
1992
|
19 |
2S3 |
p. 148-154
7 p.
|
artikel
|
| 25 |
Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson clinical trial
|
Pazdur, Richard
|
|
1992
|
19 |
2S3 |
p. 176-179
4 p.
|
artikel
|
| 26 |
Overview of N-(phosphonacetyl)-l-asparate + fluorouracil in clinical trials
|
Martin, Daniel S.
|
|
1992
|
19 |
2S3 |
p. 228-233
6 p.
|
artikel
|
| 27 |
Pharmacokinetic aspects of interferon alfa-2b after intrahepatic or intraperitoneal administration
|
Schüller, Johannes
|
|
1992
|
19 |
2S3 |
p. 98-104
7 p.
|
artikel
|
| 28 |
Principles in the biomodulation of cytotoxic drugs by interferons
|
Wadler, Scott
|
|
1992
|
19 |
2S3 |
p. 45-48
4 p.
|
artikel
|
| 29 |
Review of regional therapy of liver metastases in colorectal cancer
|
Kemeny, Nancy
|
|
1992
|
19 |
2S3 |
p. 155-162
8 p.
|
artikel
|
| 30 |
Roundtable discussion: Second international workshop on gastrointestinal cancer, recent developments in biomodulation
|
Wadler, Scott
|
|
1992
|
19 |
2S3 |
p. 234-235
2 p.
|
artikel
|
| 31 |
Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines
|
Kreuser, Ernst D.
|
|
1992
|
19 |
2S3 |
p. 73-81
9 p.
|
artikel
|
| 32 |
The emerging role for biomodulation of antineoplastic agents
|
Schmoll, H-J.
|
|
1992
|
19 |
2S3 |
p. 1-3
3 p.
|
artikel
|
| 33 |
The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer
|
Schöber, Ch.
|
|
1992
|
19 |
2S3 |
p. 131-135
5 p.
|
artikel
|
| 34 |
Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin
|
Peters, Godefridus J.
|
|
1992
|
19 |
2S3 |
p. 26-35
10 p.
|
artikel
|
| 35 |
Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: Preliminary data of a phase II study
|
Weh, Hans Josef
|
|
1992
|
19 |
2S3 |
p. 180-184
5 p.
|
artikel
|
| 36 |
Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a
|
Bernhard, Helga
|
|
1992
|
19 |
2S3 |
p. 204-207
4 p.
|
artikel
|
Tijdschrift beschrijving